COMP <GO>
HCC vs CVX // 10Y YIELD & FRED MACRO BETA
Warrior Met Coal Inc. (NYSE) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: HCC 2
— CVX 11
▲ 10Y YIELD & FRED MACRO BETA LEADER: CVX
LAST: $82.23 (-4.35%) • MKT CAP: $4.54B
macro-sensitivity
1.02
LAST: $227.77 (-3.29%) • MKT CAP: $465.33B
macro-sensitivity
1.07
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HCC VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HCC | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.40% | 41.30% | -18.90 | CVX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.80% | 5.80% | -4.00 | CVX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 46.5x | 21.5x | +25.00 | CVX | /valuation <GO> |
| Free Cash Flow Yield | 3.81% | 5.61% | -1.80 | CVX | /fcf-yield <GO> |
| Operating Margin | 3.60% | 8.10% | -4.50 | CVX | /operating-margins <GO> |
| Net Profit Margin | 4.50% | 6.70% | -2.20 | CVX | /net-margins <GO> |
| Revenue Growth (YoY) | 14.30% | -4.60% | +18.90 | HCC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.39% | 2.79% | -2.40 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.92 | 3.71 | +2.21 | HCC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.7 | 68.8 | -24.10 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.02 | 1.07 | -0.05 | CVX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 66.6x | 34.6x | +32.00 | CVX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.54B | $465.33B | -$460.79B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HCC REV | CVX REV | HCC GROSS % | CVX GROSS % | HCC FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $128.0M | $184.43B | — | 41.3% | $229.2M | $25.64B |
| FY 2024 | $713.7M | $193.41B | — | 38.4% | $367.4M | $22.79B |
| FY 2023 | $1.52B | $196.91B | — | — | $701.1M | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HCC // BETA 1.02
CVX // BETA 1.07